Having trouble viewing this email? View in your browser.
 
Weekly News
31 August 2021

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 
ESCMID Research Grants 2022: the call will close soon!

The application period for ESCMID Research Grants 2022 is only open for ten more days! The deadline to submit is 10 September 2021. For this call, only projects dealing with Bacterial Infections & Diseases will be accepted. For more information click here and please also see the Research Grants FAQ.

 
 
ESCMID Executive Committee Elections: Closing tonight!

The nomination period for new positions in the ESCMID Executive Committee, one representing clinical microbiology and two for infectious diseases, closes tonight, 31 August 2021 at 23:59 CEST. ESCMID encourages you to propose candidates on the ESCMID website.

ESCMID Online Education Courses: sign up today!

Be sure to secure your place in the exciting ESCMID online education courses coming up in the coming months. Don’t miss highlights such as ‘Paediatric infection management for the microbiologist, antimicrobial pharmacist and specialist in adult infectious diseases’, taking place from 23 - 24...

GARDP Webinar: 8 September 2021

Don’t miss the next GARDP live webinar, taking place 09:30-11:00 CEST on Wednesday,  8 September 2021. EUCIC Chairperson Evelina Tacconelli (Verona, Italy) will be presenting the topic: ‘Combination antibiotic therapy against drug-resistant Gram-negative bacteria: where the evidence stands’. Sign up...

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1

In this study, authors examined the immunogenicity and safety of the BNT162b2 mRNA vaccine in 143 people living with HIV. SARS-CoV-2 receptor binding domain IgG and neutralizing antibodies were measured and adverse events, viral load and CD4 cell counts were monitored. Data suggests that BNT162b2...